<DOC>
	<DOCNO>NCT02363725</DOCNO>
	<brief_summary>Background : Colchicine old well-known venerable drug routinely use gout attack instance . More recnetly regularly use treatment pericarditis . It couls exert antiiflammatory effect target adverse inflammation occur incase acute myocardial infarction , involve poor outcomes longer stay hospital . Endpoints : - Main endpoint : AUC CRP initial hospital stay - Secondary endpoint : - Clinical : oucomes - Imaging : ETT , MRI - Biological : various biomarkers Method Randomized , control , open-labbelled , compare two parallel arm : conventionnal optimal treatment versus conventionnal optimal treatment + colchicine</brief_summary>
	<brief_title>Interest COLchicine Treatment Patients With Acute Myocardial INfarction With Inflammatory Response</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Colchicine</mesh_term>
	<criteria>Acute myocardial inflarction ( occlusion coronary artery assess coronaro angiogram ) Adult ( 1890y ) Men / woman Aigned informed consent Health insurance Cardiogenic shock Digestive trouble Active bowel inflammatory disease ( Crhon , chronic , diarrhea ... ) Intolerance drug Renal insufficiency clearance &lt; 30mL/min Immunosuppression , aplasia Active infectious disease , active know neoplasia , chronic inflammatory disease Hypersensitivity , allergy one study components Active liver disease Poor hemodynamic condition Recent severe sepsis Chronic treatment corticoid steroid antiinflammatory agent No possibility inform consent Protected law Poor abservance History toxicomania , suicice attempt Pregnacy , breeding , project pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Acute myocardial infarction</keyword>
	<keyword>Inflammation</keyword>
	<keyword>CRP</keyword>
	<keyword>Colchicine</keyword>
</DOC>